• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

滤泡细胞源性甲状腺肿瘤细针穿刺物琼脂糖细胞块上半乳糖凝集素-3和HBME-1的表达

Galectin-3 and HBME-1 Expression on Agarose Cell Blocks from Fine-needle aspirates of Follicular Cell-derived Thyroid Tumors.

作者信息

Abu-Sinna E, Hasan M Y, El-Deftar M M, Amer S A, Abdelsalam L O, Nakhla J A

机构信息

Department of Pathology, National Cancer Institute, Cairo University, Faculty of Medicine, Cairo University, Egypt.

Department of Pathology, Faculty of Medicine, Cairo University, Egypt.

出版信息

J Cytol. 2018 Jan-Mar;35(1):27-32. doi: 10.4103/JOC.JOC_67_17.

DOI:10.4103/JOC.JOC_67_17
PMID:29403166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5795724/
Abstract

AIM

To test the expression of galectin-3 (gal-3) and Hector Battifora mesothelial antigen-1 (HBME-1) on agarose cell blocks (CBs) of fine-needle aspirates aiming to determine their diagnostic value in thyroid follicle cell-derived tumors.

MATERIALS AND METHODS

Forty patients with thyroid nodule were enrolled. Fine-needle aspiration biopsy was done and processed to produce smears and CBs. Immune staining was done on CBs using antibodies to gal-3 and HBME-1. Diagnostic value of tests was determined in comparison to pathology.

RESULTS

Current study included 17 papillary thyroid carcinoma (PTC), 15 follicular adenoma, and 8 follicular thyroid carcinoma (FTC). In PTC diagnosis, co-expression of gal-3/HBME-1 had a sensitivity of 94.1%, specificity of 73.3%, positive predictive value (PPV) of 80%, negative predictive value (NPV) 91.7%, and accuracy of 84.4%. In FTC diagnosis, combined gal-3/HBME-1 expression had a sensitivity of 75%, specificity of 78.6%, PPV of 50%, NPV of 91.7%, and accuracy of 77.8%. Co-expression of gal-3/HBME-1 raised the sensitivity of detection of differentiated thyroid carcinomas from 40% with cytomorphology to 92% and accuracy from 62.5% to 85%.

CONCLUSION

The combined immunocytochemical expression of gal-3 and HBME-1 utilizing fine-needle aspirates can improve the sensitivity of detection and diagnostic accuracy of differentiated follicular cell-derived thyroid carcinomas.

摘要

目的

检测细针穿刺抽吸物的琼脂糖细胞块(CBs)上半乳糖凝集素-3(gal-3)和赫克托·巴蒂福拉间皮抗原-1(HBME-1)的表达,旨在确定其在甲状腺滤泡细胞源性肿瘤中的诊断价值。

材料与方法

纳入40例甲状腺结节患者。进行细针穿刺活检并制作涂片和细胞块。使用抗gal-3和HBME-1抗体对细胞块进行免疫染色。与病理结果比较确定检测的诊断价值。

结果

本研究包括17例乳头状甲状腺癌(PTC)、15例滤泡性腺瘤和8例滤泡状甲状腺癌(FTC)。在PTC诊断中,gal-3/HBME-1的共表达敏感性为94.1%,特异性为73.3%,阳性预测值(PPV)为80%,阴性预测值(NPV)为91.7%,准确性为84.4%。在FTC诊断中,gal-3/HBME-1联合表达敏感性为75%,特异性为78.6%,PPV为50%,NPV为91.7%,准确性为77.8%。gal-3/HBME-1的共表达将分化型甲状腺癌的检测敏感性从细胞形态学的40%提高到92%,准确性从62.5%提高到85%。

结论

利用细针穿刺抽吸物联合检测gal-3和HBME-1的免疫细胞化学表达可提高分化型滤泡细胞源性甲状腺癌的检测敏感性和诊断准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e811/5795724/ecfa36dcd1a0/JCytol-35-27-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e811/5795724/9bb0357e3514/JCytol-35-27-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e811/5795724/ecfa36dcd1a0/JCytol-35-27-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e811/5795724/9bb0357e3514/JCytol-35-27-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e811/5795724/ecfa36dcd1a0/JCytol-35-27-g003.jpg

相似文献

1
Galectin-3 and HBME-1 Expression on Agarose Cell Blocks from Fine-needle aspirates of Follicular Cell-derived Thyroid Tumors.滤泡细胞源性甲状腺肿瘤细针穿刺物琼脂糖细胞块上半乳糖凝集素-3和HBME-1的表达
J Cytol. 2018 Jan-Mar;35(1):27-32. doi: 10.4103/JOC.JOC_67_17.
2
CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1.CXCL12 趋化因子受体 4 在甲状腺滤泡型乳头状癌中的免疫检测:与半乳糖凝集素-3 和 Hector Battifora 间皮细胞-1 的比较。
Thyroid. 2010 May;20(5):495-504. doi: 10.1089/thy.2009.0282.
3
Differences of HBME-1 Expression in Thyroid Follicular Adenoma and Follicular Thyroid Carcinoma by Ultrasound-Guided Fine-Needle Aspiration Biopsy.超声引导下细针穿刺活检检测甲状腺滤泡性腺瘤和滤泡状甲状腺癌中HBME-1表达的差异
J Coll Physicians Surg Pak. 2019 Apr;29(4):337-340. doi: 10.29271/jcpsp.2019.04.337.
4
Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.HBME-1和半乳糖凝集素-3的免疫组化表达在滤泡性甲状腺结节鉴别诊断中的应用
Pathol Res Pract. 2014 Dec;210(12):971-8. doi: 10.1016/j.prp.2014.06.010. Epub 2014 Jun 27.
5
Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV.恶性肿瘤标志物在甲状腺结节细针穿刺细胞学检查中的应用:赫克托·巴蒂福拉间皮抗原-1、甲状腺过氧化物酶和二肽基肽酶IV的比较
Br J Cancer. 2008 Feb 26;98(4):818-23. doi: 10.1038/sj.bjc.6604194. Epub 2008 Jan 22.
6
Immune characterization of thyroid neoplasm's and its variants using immunohistochemical markers: CK-19, Galectin-3 and Hector Battifora mesothelial-1.使用免疫组织化学标志物对甲状腺肿瘤及其变体进行免疫特征分析:CK-19、半乳糖凝集素-3 和 Hector Battifora 间皮素-1。
Ann Diagn Pathol. 2022 Jun;58:151931. doi: 10.1016/j.anndiagpath.2022.151931. Epub 2022 Mar 2.
7
Value of cytokeratin-19, Hector Battifora mesothelial-1 and galectin-3 immunostaining in the diagnosis of thyroid neoplasms.细胞角蛋白-19、赫克托·巴蒂福拉间皮素-1和半乳糖凝集素-3免疫染色在甲状腺肿瘤诊断中的价值。
J Lab Physicians. 2018 Apr-Jun;10(2):200-207. doi: 10.4103/JLP.JLP_106_17.
8
Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy.通过细针穿刺活检检测半乳糖凝集素-3、细胞角蛋白19、人甲状腺转录因子-1及Ret原癌蛋白的差异表达在甲状腺肿瘤诊断中的应用
Cytojournal. 2009 Sep 18;6:18. doi: 10.4103/1742-6413.55894.
9
Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer.半乳糖凝集素-3、细胞角蛋白19和人甲状腺转录因子-1免疫染色联合应用可提高甲状腺癌的诊断水平。
Oncol Lett. 2017 Oct;14(4):4183-4189. doi: 10.3892/ol.2017.6719. Epub 2017 Aug 4.
10
[Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].GADD153在甲状腺滤泡性肿瘤中的表达及其与CK19、Galectin-3和HBME-1的比较
Zhonghua Bing Li Xue Za Zhi. 2011 Nov;40(11):745-8.

引用本文的文献

1
Follicular Growth Pattern Disease on Thyroid Fine-needle Aspiration Biopsy.甲状腺细针抽吸活检中的滤泡生长模式疾病。
Balkan Med J. 2022 Jul 22;39(4):230-238. doi: 10.4274/balkanmedj.galenos.2022.2022-5-17. Epub 2022 Jun 20.
2
Challenge in the Pathological Diagnosis of the Follicular- Patterned Thyroid Lesions.滤泡性甲状腺病变的病理诊断挑战。
Asian Pac J Cancer Prev. 2021 Oct 1;22(10):3365-3376. doi: 10.31557/APJCP.2021.22.10.3365.
3
A Naturally Derived Carrier for Photodynamic Treatment of Squamous Cell Carcinoma: In Vitro and In Vivo Models.

本文引用的文献

1
The State of Cell Blocks and Ancillary Testing: Past, Present, and Future.细胞块及辅助检测的现状:过去、现在与未来
Arch Pathol Lab Med. 2016 Dec;140(12):1318-1322. doi: 10.5858/arpa.2016-0125-RA. Epub 2016 Aug 24.
2
Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature.通过系统文献回顾确定CD56、细胞角蛋白19、半乳糖凝集素3和人甲状腺髓样癌单克隆抗体1在甲状腺滤泡细胞源性病变诊断中的价值。
Diagn Pathol. 2015 Oct 26;10:196. doi: 10.1186/s13000-015-0428-4.
3
Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity?
一种用于光动力治疗鳞状细胞癌的天然衍生载体:体外和体内模型
Pharmaceutics. 2020 May 29;12(6):494. doi: 10.3390/pharmaceutics12060494.
4
A Monocentric Retrospective Study about the Correlation between Histology and Cytology of Thyroid Indeterminate Nodules Classified as TIR 3A and TIR 3B, according to 2014 Italian Consensus for Classification and Reporting of Thyroid Cytology.一项关于根据2014年意大利甲状腺细胞病理学分类与报告共识被分类为TIR 3A和TIR 3B的甲状腺不确定结节组织学与细胞学相关性的单中心回顾性研究。
Adv Med. 2019 Oct 8;2019:3932721. doi: 10.1155/2019/3932721. eCollection 2019.
免疫组化标志物联合染色在甲状腺乳头状癌诊断中的应用:敏感性或特异性的提高?
J Int Med Res. 2013 Aug;41(4):975-83. doi: 10.1177/0300060513490617. Epub 2013 Jul 15.
4
Effectiveness of the cell block technique in diagnostic cytopathology.细胞块技术在诊断性细胞病理学中的有效性。
J Cytol. 2012 Jul;29(3):177-82. doi: 10.4103/0970-9371.101167.
5
Galectin-3 expression in thyroid fine needle cytology (t-FNAC) uncertain cases: validation of molecular markers and technology innovation.甲状腺细针细胞学(t-FNAC)不确定病例中半乳糖凝集素-3 的表达:分子标志物的验证和技术创新。
J Cell Physiol. 2013 May;228(5):968-74. doi: 10.1002/jcp.24242.
6
Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis.CK-19、半乳糖凝集素-3 和 HBME-1 在甲状腺病变分化中的表达:系统评价和诊断荟萃分析。
Diagn Pathol. 2012 Aug 13;7:97. doi: 10.1186/1746-1596-7-97.
7
Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control.免疫细胞化学检测细胞角蛋白 19 和抗人间皮细胞抗体 (HBME1) 可提高甲状腺细针抽吸的诊断准确性:附有组织学对照的 150 例液体基细针抽吸术的初步报告。
Thyroid. 2011 Oct;21(10):1067-73. doi: 10.1089/thy.2011.0014. Epub 2011 Aug 29.
8
Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology.滤泡性甲状腺肿瘤可根据液基细针细胞学 HBME-1 和半乳糖凝集素-3 的表达进行低风险和高风险分类。
Eur J Endocrinol. 2011 Sep;165(3):447-53. doi: 10.1530/EJE-11-0181. Epub 2011 Jul 1.
9
Thyroid cytopathology: Bethesda and beyond.甲状腺细胞病理学:贝塞斯达及其他。
Acta Cytol. 2011;55(1):4-12. doi: 10.1159/000322365. Epub 2010 Nov 26.
10
Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.CK19、RET、半乳糖凝集素-3 和 HBME-1 表达对甲状腺乳头状癌的诊断意义。
J Clin Pathol. 2010 Sep;63(9):786-9. doi: 10.1136/jcp.2010.076901. Epub 2010 Jul 19.